Pulse Biosciences, Inc. is a cutting-edge healthcare company in the United States that focuses on bioelectric medicine. The company utilizes its patented Nano-Pulse Stimulation technology, which delivers nanosecond-duration pulses of electrical energy to clear targeted cells without harming surrounding tissue. This innovative approach, also known as Nanosecond Pulsed-Field Ablation (nsPFA) technology, can address various medical conditions. With a risk rating score of 34.2, Pulse Biosciences is classified as high risk. The company generates significant revenue, mainly in North America, through the sale of its systems.